Establishment of Immortalized Human Erythroid Progenitor Cell Lines Able to Produce Enucleated Red Blood Cells
Open accessThe DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Transfusion of red blood cells (RBCs) is a standard and indispensable therapy in current clinical practice. In vitro production of RBCs offers a potential means to overcome a shortage of transfusable RBCs in some clinical situations and also to provide a source of cells free from possible infection or contamination by microorganisms. Thus, in vitro production of RBCs may become a standard procedure in the future. We previously reported the successful establishment of immortalized mouse erythroid progenitor cell lines that were able to produce mature RBCs very efficiently. Here, we have developed a reliable protocol for establishing immortalized human erythroid progenitor cell lines that are able to produce enucleated RBCs. These immortalized cell lines produce functional hemoglobin and express erythroid-specific markers, and these markers are upregulated following induction of differentiation in vitro. Most importantly, these immortalized cell lines all produce enucleated RBCs after induction of differentiation in vitro, although the efficiency of producing enucleated RBCs remains to be improved further. To the best of our knowledge, this is the first demonstration of the feasibility of using immortalized human erythroid progenitor cell lines as an ex vivo source for production of enucleated RBCs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






![Figure 7 Gene expression profiles of the established erythroid progenitor cell lines estimated by quantitative RT-PCR analysis. Analyzed genes are indicated. FL, results with cDNA derived from human fetal liver. Relative expression was evaluated compared to that of FL. CB, cord blood. CB 6, 10 and 16, results with cDNA derived from cultured erythroid cells, i.e., CD34-positive cells in CB were induced to differentiate into mature erythroid cells for 6, 10 and 16 days, respectively, using the previously reported method [4]. B and A, Before and 2 days after induction of differentiation of HiDEP and HUDEP cells.](https://figures.cochat.ai/paper-figures/2c1a4cd9be89480c8e81cf1b067b0b83/establishment-of-immortalized-human-erythroid-progenitor-cell-lines-able-to-figure-7.jpg)



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Furthermore, overexpression of CBL and CNN1 transgenes in a human erythroid progenitor model (HUDEP2 cells) individually and in combination also induced markers of erythroid differentiation (Fig. 3F–G and fig. S10C–D) (21).”
From Exploring genetic interaction manifolds constructed from rich single-cell phenotypes (2019) · cites this paper as [21]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007) · Cell · doi:10.1016/j.cell.2007.11.019 · Cited by 20,221
Tight control of gene expression in mammalian cells by tetracycline-responsive promoters.
Gossen, M., & Bujard, H. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.12.5547 · Cited by 4,943 · cited 1×
“In order to test this possibility, we used a Tet-inducible expression system [18,19] to control expression of HPV16-E6/ E7 in iPS-derived hematopoietic progenitor cells and investigated whether such expression inhibited establishment of immortalized erythroid progenitor cell lines.”
MethodTranscriptional Activation by Tetracyclines in Mammalian Cells
Gossen, M., Freundlieb, S., Bender, G., Müller, G., Hillen, W., & Bujard, H. (1995) · Science · doi:10.1126/science.7792603 · Cited by 2,488 · cited 1×
“In order to test this possibility, we used a Tet-inducible expression system [18,19] to control expression of HPV16-E6/ E7 in iPS-derived hematopoietic progenitor cells and investigated whether such expression inhibited establishment of immortalized erythroid progenitor cell lines.”
MethodHuman Fetal Hemoglobin Expression Is Regulated by the Developmental Stage-Specific Repressor BCL11A
Sankaran, V. G., Menne, T. F., Xu, J., Akie, T. E., Lettre, G., Van Handel, B., Mikkola, H. K. A., Hirschhorn, J. N., Cantor, A. B., & Orkin, S. H. (2008) · Science · doi:10.1126/science.1165409 · Cited by 919
Absence of yolk sac hematopoiesis from mice with a targeted disruption of the scl gene.
Robb, L., Lyons, I., Li, R., Hartley, L., Köntgen, F., Harvey, R. P., Metcalf, D., & Begley, C. G. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.15.7075 · Cited by 577 · cited 1×
“TAL1 plays essential roles in early hematopoiesis [13] and differentiation of erythroid cells and megakaryocytes [14,15].”
BackgroundDevelopmental and species-divergent globin switching are driven by BCL11A
Sankaran, V. G., Xu, J., Ragoczy, T., Ippolito, G. C., Walkley, C. R., Maika, S. D., Fujiwara, Y., Ito, M., Groudine, M., Bender, M. A., et al. (2009) · Nature · doi:10.1038/nature08243 · Cited by 379 · cited 1×
“Of note, BCL11A, a repressor of c-globin expression [25] and critical mediator of globin switching [26], was abundantly detected only in the HUDEP-2 cell line in which b-globin was up-regulated after differentiation (Figure 7).”
BackgroundMikkola, H. K. A., Klintman, J., Yang, H., Hock, H., Schlaeger, T. M., Fujiwara, Y., & Orkin, S. H. (2003) · Nature · doi:10.1038/nature01345 · Cited by 371 · cited 1×
“TAL1 plays essential roles in early hematopoiesis [13] and differentiation of erythroid cells and megakaryocytes [14,15].”
BackgroundProof of principle for transfusion of in vitro–generated red blood cells
Giarratana, M.-C., Rouard, H., Dumont, A., Kiger, L., Safeukui, I., Le Pennec, P.-Y., François, S., Trugnan, G., Peyrard, T., Marie, T., et al. (2011) · Blood · doi:10.1182/blood-2011-06-362038 · Cited by 342
KARASAWA, S., ARAKI, T., NAGAI, T., MIZUNO, H., & MIYAWAKI, A. (2004) · Biochemical Journal · doi:10.1042/bj20040321 · Cited by 342 · cited 1×
“The CSIV-TRE-RfA-UbC-KT lentiviral vector plasmid (Figure S2) contains the humanized Kusabira-Orange 1 (hKO1) fluorescent protein gene [11] and the reverse tetracycline (Tet)-controlled transcriptional transactivator (TAKARA BIO) linked by the Thosea asigna virus 2A peptide sequence under the control of human ubiquiti…”
BackgroundBiologic properties and enucleation of red blood cells from human embryonic stem cells
Lu, S.-J., Feng, Q., Park, J. S., Vida, L., Lee, B.-S., Strausbauch, M., Wettstein, P. J., Honig, G. R., & Lanza, R. (2008) · Blood · doi:10.1182/blood-2008-05-157198 · Cited by 293 · cited 1×
“in vitro [1,2,3] from hematopoietic stem/progenitor cells [4,5], embryonic stem (ES) cells [6], or induced pluripotent stem (iPS) cells [7].”
Background
Cited by
BCL11A enhancer dissection by Cas9-mediated in situ saturating mutagenesis
Canver, M. C., Smith, E. C., Sher, F., Pinello, L., Sanjana, N. E., Shalem, O., Chen, D. D., Schupp, P. G., Vinjamur, D. S., Garcia, S. P., et al. (2015) · Nature · doi:10.1038/nature15521 · Cited by 886
Self-citationDirect promoter repression by BCL11A controls the fetal to adult hemoglobin switch
Liu, N., Hargreaves, V. V., Zhu, Q., Kurland, J. V., Hong, J., Kim, W., Sher, F., Macias-Trevino, C., Rogers, J. M., Kurita, R., et al. (2018) · Cell · doi:10.1016/j.cell.2018.03.016 · Cited by 478
“BCL11A CUT&RUN was performed in expansion-phase HUDEP-2 cells (Kurita et al., 2013) and primary human stem/progenitor CD34 cells (Xu et al.”
BackgroundMethodInfluentialSelf-citationExploring genetic interaction manifolds constructed from rich single-cell phenotypes
Norman, T. M., Horlbeck, M. A., Replogle, J. M., Ge, A. Y., Xu, A., Jost, M., Gilbert, L. A., & Weissman, J. S. (2019) · Science · doi:10.1126/science.aax4438 · Cited by 392
Transcription factors LRF and BCL11A independently repress expression of fetal hemoglobin
Masuda, T., Wang, X., Maeda, M., Canver, M. C., Sher, F., Funnell, A. P. W., Fisher, C., Suciu, M., Martyn, G. E., Norton, L. J., et al. (2016) · Science · doi:10.1126/science.aad3312 · Cited by 373
Self-citationTraxler, E. A., Yao, Y., Wang, Y.-D., Woodard, K. J., Kurita, R., Nakamura, Y., Hughes, J. R., Hardison, R. C., Blobel, G. A., Li, C., et al. (2016) · Nature Medicine · doi:10.1038/nm.4170 · Cited by 366
Self-citationMartyn, G. E., Wienert, B., Yang, L., Shah, M., Norton, L. J., Burdach, J., Kurita, R., Nakamura, Y., Pearson, R. C. M., Funnell, A. P. W., et al. (2018) · Nature Genetics · doi:10.1038/s41588-018-0085-0 · Cited by 300
Self-citationDual base editor catalyzes both cytosine and adenine base conversions in human cells
Zhang, X., Zhu, B., Chen, L., Xie, L., Yu, W., Wang, Y., Li, L., Yin, S., Yang, L., Hu, H., et al. (2020) · Nature Biotechnology · doi:10.1038/s41587-020-0527-y · Cited by 272
Self-citationTrakarnsanga, K., Griffiths, R. E., Wilson, M. C., Blair, A., Satchwell, T. J., Meinders, M., Cogan, N., Kupzig, S., Kurita, R., Nakamura, Y., et al. (2017) · Nature Communications · doi:10.1038/ncomms14750 · Cited by 204
“We set out to create immortalized adult erythroid lines, utilizing a Tet-inducible HPV16-E6/E7 expression system 8 .”
MethodSelf-citationInduction of fetal hemoglobin synthesis by CRISPR/Cas9-mediated editing of the human β-globin locus
Antoniani, C., Meneghini, V., Lattanzi, A., Felix, T., Romano, O., Magrin, E., Weber, L., Pavani, G., El Hoss, S., Kurita, R., et al. (2018) · Blood · doi:10.1182/blood-2017-10-811505 · Cited by 194
Self-citationIdentification of LZTFL1 as a candidate effector gene at a COVID-19 risk locus
Downes, D. J., Cross, A. R., Hua, P., Roberts, N., Schwessinger, R., Cutler, A. J., Munis, A. M., Brown, J., Mielczarek, O., de Andrea, C. E., et al. (2021) · Nature Genetics · doi:10.1038/s41588-021-00955-3 · Cited by 173
Advances in understanding erythropoiesis: evolving perspectives
Nandakumar, S. K., Ulirsch, J. C., & Sankaran, V. G. (2016) · British Journal of Haematology · doi:10.1111/bjh.13938 · Cited by 172
“More recently, immortalized human erythroid cell lines have been created through a variety of methods, and some of these lines may be valuable in 210 ª 2016 John Wiley & Sons Ltd British Journal of Haematology, 2016, 173, 206–218 future studies (Kurita et al, 2013).”
BackgroundTranscriptional States and Chromatin Accessibility Underlying Human Erythropoiesis
Ludwig, L. S., Lareau, C. A., Bao, E. L., Nandakumar, S. K., Muus, C., Ulirsch, J. C., Chowdhary, K., Buenrostro, J. D., Mohandas, N., An, X., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.05.046 · Cited by 166
“Consistent with a role in TMCC2 gene regulation, we observed significant downregulation of transcript levels as measured by qRT-PCR upon targeting the promoter or enhancer of TMCC2 with two independent guide RNAs in HUDEP-2 cells (Kurita et al., 2013), which was more pronounced when targeting the promoter (Figure 6E).”
BackgroundDomain-focused CRISPR screen identifies HRI as a fetal hemoglobin regulator in human erythroid cells
Grevet, J. D., Lan, X., Hamagami, N., Edwards, C. R., Sankaranarayanan, L., Ji, X., Bhardwaj, S. K., Face, C. J., Posocco, D. F., Abdulmalik, O., et al. (2018) · Science · doi:10.1126/science.aao0932 · Cited by 153
Bauer, D. E., & Orkin, S. H. (2015) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2015.08.001 · Cited by 143
Weber, L., Frati, G., Felix, T., Hardouin, G., Casini, A., Wollenschlaeger, C., Meneghini, V., Masson, C., De Cian, A., Chalumeau, A., et al. (2020) · Science Advances · doi:10.1126/sciadv.aay9392 · Cited by 140
“HUDEP-2 cells (46) were cultured and differentiated, as previously described (47).”
MethodAcute depletion of CTCF directly affects MYC regulation through loss of enhancer–promoter looping
Hyle, J., Zhang, Y., Wright, S., Xu, B., Shao, Y., Easton, J., Tian, L., Feng, R., Xu, P., & Li, C. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz462 · Cited by 139
“Notably, MYC expression was not profoundly affected upon CTCF loss in HUDEP-2 cells suggesting that CTCF could play a B-ALL cell line specific role in maintaining MYC expression.”
MethodInfluentialHuang, P., Keller, C. A., Giardine, B., Grevet, J. D., Davies, J. O. J., Hughes, J. R., Kurita, R., Nakamura, Y., Hardison, R. C., & Blobel, G. A. (2017) · Genes & Development · doi:10.1101/gad.303461.117 · Cited by 127
“5A; Kurita et al. 2013).”
Self-citationEmerging genetic therapy for sickle cell disease
Orkin, S. H., & Bauer, D. E. (2019) · Annual Review of Medicine · doi:10.1146/annurev-med-041817-125507 · Cited by 119
Recent progress in understanding and manipulating haemoglobin switching for the haemoglobinopathies
Vinjamur, D. S., Bauer, D. E., & Orkin, S. H. (2018) · British Journal of Haematology · doi:10.1111/bjh.15038 · Cited by 114
“A major boost to the repertoire of cel- lular models for the study of switching came in 2013 with the establishment of the human umbilical cord blood-derived erythroid progenitor (HUDEP-2) cell line by immortalization of umbilical cord blood CD34+ cells (Kurita et al, 2013).”
BackgroundRational targeting of a NuRD subcomplex guided by comprehensive in situ mutagenesis
Sher, F., Hossain, M., Seruggia, D., Schoonenberg, V. A. C., Yao, Q., Cifani, P., Dassama, L. M. K., Cole, M. A., Ren, C., Vinjamur, D. S., et al. (2019) · Nature Genetics · doi:10.1038/s41588-019-0453-4 · Cited by 111
Self-citationCanver, M. C., Lessard, S., Pinello, L., Wu, Y., Ilboudo, Y., Stern, E. N., Needleman, A. J., Galactéros, F., Brugnara, C., Kutlar, A., et al. (2017) · Nature Genetics · doi:10.1038/ng.3793 · Cited by 105
“For the HBS1L-MYB saturating-mutagenesis experiments, we used the immortalized human erythroid cell line HUDEP-2, which has previously been used to examine erythroid maturation and HbF regulation 3,31 .”
MethodSelf-citationAn Oncogenic Protein Golgi Phosphoprotein 3 Up-regulates Cell Migration via Sialylation
Isaji, T., Im, S., Gu, W., Wang, Y., Hang, Q., Lu, J., Fukuda, T., Hashii, N., Takakura, D., Kawasaki, N., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.542688 · Cited by 99
“The CSIV-TRE-RfA-CMV-KT lentiviral vector was constructed by replacement of the EF promoter with CMV in CSIV-TRE-RfA-EF-KT vector (31, 32) The expression vectors pEF puro-RfA and pcDNA3.”
MethodSelf-citationKoya, J., Kataoka, K., Sato, T., Bando, M., Kato, Y., Tsuruta-Kishino, T., Kobayashi, H., Narukawa, K., Miyoshi, H., Shirahige, K., et al. (2016) · Nature Communications · doi:10.1038/ncomms10924 · Cited by 97
Self-citationZNF410 Uniquely Activates the NuRD Component CHD4 to Silence Fetal Hemoglobin Expression
Lan, X., Ren, R., Feng, R., Ly, L. C., Lan, Y., Zhang, Z., Aboreden, N. G., Qin, K., Horton, J. R., Grevet, J. D., et al. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.11.006 · Cited by 97
KLF1 drives the expression of fetal hemoglobin in British HPFH
Wienert, B., Martyn, G. E., Kurita, R., Nakamura, Y., Quinlan, K. G. R., & Crossley, M. (2017) · Blood · doi:10.1182/blood-2017-02-767400 · Cited by 93
Self-citationLi, C., Georgakopoulou, A., Mishra, A., Gil, S., Hawkins, R. D., Yannaki, E., & Lieber, A. (2021) · Blood Advances · doi:10.1182/bloodadvances.2020003702 · Cited by 100
Park, S. H., Cao, M., Pan, Y., Davis, T. H., Saxena, L., Deshmukh, H., Fu, Y., Treangen, T., Sheehan, V. A., & Bao, G. (2022) · Science Advances · doi:10.1126/sciadv.abo7676 · Cited by 93
“…SFEM medium (STEMCELL Technologies) supplemented with recombinant human stem cell factor (50 ng/ml; PeproTech, 300-07), recombinant human erythropoietin (20 ng/ml; PeproTech, 100-64), dexamethasone (1 M; Sigma-Aldrich, D8893), and doxycycline hydrochloride (1 g/ml; Sigma-Aldrich, D3072) ( 29 ).”
InfluentialLong non-coding RNA-dependent mechanism to regulate heme biosynthesis and erythrocyte development
Liu, J., Li, Y., Tong, J., Gao, J., Guo, Q., Zhang, L., Wang, B., Zhao, H., Wang, H., Jiang, E., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-06883-x · Cited by 96
Self-citationTranscription factor competition at the γ-globin promoters controls hemoglobin switching
Liu, N., Xu, S., Yao, Q., Zhu, Q., Kai, Y., Hsu, J. Y., Sakon, P., Pinello, L., Yuan, G.-C., Bauer, D. E., et al. (2021) · Nature Genetics · doi:10.1038/s41588-021-00798-y · Cited by 86
Giani, F. C., Fiorini, C., Wakabayashi, A., Ludwig, L. S., Salem, R. M., Jobaliya, C. D., Regan, S. N., Ulirsch, J. C., Liang, G., Steinberg-Shemer, O., et al. (2016) · Cell Stem Cell · doi:10.1016/j.stem.2015.09.015 · Cited by 86
“Despite promising recent advances (Hirose et al., 2013; Huang et al., 2014; Kurita et al., 2013), no immortalized human cell lines allow consistent differentiation into mature RBCs.”
Khalil, S., Delehanty, L., Grado, S., Holy, M., White, Z., Freeman, K., Kurita, R., Nakamura, Y., Bullock, G., & Goldfarb, A. (2018) · Journal of Experimental Medicine · doi:10.1084/jem.20170396 · Cited by 84
“To circumvent this limitation, we also knocked down Scribble in HUD EP-2 cells, a nontransformed human erythroblast cell line (Kurita et al., 2013).”
BackgroundMethodInfluentialSelf-citationHirose, S.-I., Takayama, N., Nakamura, S., Nagasawa, K., Ochi, K., Hirata, S., Yamazaki, S., Yamaguchi, T., Otsu, M., Sano, S., et al. (2013) · Stem Cell Reports · doi:10.1016/j.stemcr.2013.10.010 · Cited by 97
“1 j 499–508 j December 17, 2013 j a2013 The genitor cell line and a humanCB-derived erythroid progenitor cell line through transduction of HPV16-E6/E7 (Kurita et al., 2013).”
BackgroundInfluentialPavani, G., Fabiano, A., Laurent, M., Amor, F., Cantelli, E., Chalumeau, A., Maule, G., Tachtsidi, A., Concordet, J., Cereseto, A., et al. (2021) · Blood Advances · doi:10.1182/bloodadvances.2020001996 · Cited by 104
Potent and uniform fetal hemoglobin induction via base editing
Mayuranathan, T., Newby, G. A., Feng, R., Yao, Y., Mayberry, K. D., Lazzarotto, C. R., Li, Y., Levine, R. M., Nimmagadda, N., Dempsey, E., et al. (2023) · Nature Genetics · doi:10.1038/s41588-023-01434-7 · Cited by 92
ZNF410 represses fetal globin by singular control of CHD4
Vinjamur, D. S., Yao, Q., Cole, M. A., McGuckin, C., Ren, C., Zeng, J., Hossain, M. A., Luk, K., Wolfe, S. A., Pinello, L., et al. (2021) · Nature Genetics · doi:10.1038/s41588-021-00843-w · Cited by 90
Antoniou, P., Hardouin, G., Martinucci, P., Frati, G., Félix, T., Chalumeau, A., Fontana, L., Martin, J., Masson, C., Brusson, M., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-34493-1 · Cited by 88
Huang, P., Peslak, S. A., Lan, X., Khandros, E., Yano, J. A., Sharma, M., Keller, C. A., Giardine, B. M., Qin, K., Abdulmalik, O. Y., et al. (2020) · Blood · doi:10.1182/blood.2020005301 · Cited by 81
Practical Use of Immortalized Cells in Medicine: Current Advances and Future Perspectives
Voloshin, N., Tyurin-Kuzmin, P., Karagyaur, M., Akopyan, Z., & Kulebyakin, K. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241612716 · Cited by 77
“Although the efficiency of differentiation of these cells into non-nuclear erythrocytes was low and only one line (HUDEP-2) expressed 2-alpha-2-beta hemoglobin (while others expressed fetal forms of hemoglobin), this is the first study in which immortalized erythroid progenitors able to differentiate into cells compar…”
An erythroid-specific ATP2B4 enhancer mediates red blood cell hydration and malaria susceptibility
Lessard, S., Gatof, E. S., Beaudoin, M., Schupp, P. G., Sher, F., Ali, A., Prehar, S., Kurita, R., Nakamura, Y., Baena, E., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci94378 · Cited by 82
“To test this hypothesis, we deleted this region in a human erythroid precursor cell line (HUDEP-2) using the CRISPR-Cas9 system (21).”
BackgroundMethodSelf-citationMartyn, G. E., Wienert, B., Kurita, R., Nakamura, Y., Quinlan, K. G. R., & Crossley, M. (2019) · Blood · doi:10.1182/blood-2018-07-863951 · Cited by 85
Self-citationLi, C., Wang, H., Georgakopoulou, A., Gil, S., Yannaki, E., & Lieber, A. (2020) · Molecular Therapy · doi:10.1016/j.ymthe.2020.09.001 · Cited by 80
Ravi, N. S., Wienert, B., Wyman, S. K., Bell, H. W., George, A., Mahalingam, G., Vu, J. T., Prasad, K. M., Bandlamudi, B. P., Devaraju, N., et al. (2022) · eLife · doi:10.7554/elife.65421 · Cited by 78
“The shift in expression of CD71 positive cells alone to CD71/CD235a double positive cells reflects the erythroid differentiation pattern of HUDEP2 cells (Kurita et al., 2013).”
BackgroundMethodSelf-citationLi, C., Psatha, N., Gil, S., Wang, H., Papayannopoulou, T., & Lieber, A. (2018) · Molecular Therapy - Methods & Clinical Development · doi:10.1016/j.omtm.2018.04.008 · Cited by 71
“The ability of HDAd-Acr to block CRISPR/Cas9 cleavage was first tested in Human Umbilical cord blood-Derived Erythroid Progenitor (HUDEP-2) cells.(28) Upon culture in erythroid differentiation media, HUDEP-2 cells closely resemble adult erythroid cells because they express predominantly b-globin.”
Sadahiro, T., Isomi, M., Muraoka, N., Kojima, H., Haginiwa, S., Kurotsu, S., Tamura, F., Tani, H., Tohyama, S., Fujita, J., et al. (2018) · Cell stem cell · doi:10.1016/j.stem.2018.07.001 · Cited by 76
Self-citationActivation of γ-globin expression by hypoxia-inducible factor 1α
Feng, R., Mayuranathan, T., Huang, P., Doerfler, P. A., Li, Y., Yao, Y., Zhang, J., Palmer, L. E., Mayberry, K. D., Christakopoulos, G. E., et al. (2022) · Nature · doi:10.1038/s41586-022-05312-w · Cited by 74
Trakarnsanga, K., Wilson, M. C., Lau, W. W. Y., Singleton, B. K., Parsons, S. F., Sakuntanaga, P., Kurita, R., Nakamura, Y., Anstee, D. J., & Frayne, J. (2014) · Haematologica · doi:10.3324/haematol.2014.110155 · Cited by 76
“throblast stage by transduction with inducible HPV-type 16E6/E7.(3) HiDEP-1 cells were maintained in Stemspan SFEM (Stem Cell Technology) with 3U.”
MethodSelf-citationThe Shape Shifting Story of Reticulocyte Maturation
Ovchynnikova, E., Aglialoro, F., Lindern, M. V., & van den Akker, E. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00829 · Cited by 76
“In contrast, enucleation is generally poor in immortalized cell lines and erythroid cells derived from induced pluripotent stem cells (Lapillonne et al., 2010; Kurita et al., 2013; Trakarnsanga et al., 2017) [reviewed by (Focosi and Amabile, 2017)].”
BackgroundLarge‐scale production of red blood cells from stem cells: What are the technical challenges ahead?
Rousseau, G. F., Giarratana, M., & Douay, L. (2013) · Biotechnology Journal · doi:10.1002/biot.201200368 · Cited by 81
KLF1 directly activates expression of the novel fetal globin repressor ZBTB7A/LRF in erythroid cells
Norton, L. J., Funnell, A. P. W., Burdach, J., Wienert, B., Kurita, R., Nakamura, Y., Philipsen, S., Pearson, R. C. M., Quinlan, K. G. R., & Crossley, M. (2017) · Blood Advances · doi:10.1182/bloodadvances.2016002303 · Cited by 65
Self-citationDoerfler, P. A., Feng, R., Li, Y., Palmer, L. E., Porter, S. N., Bell, H. W., Crossley, M., Pruett‐Miller, S. M., Cheng, Y., & Weiss, M. J. (2021) · Nature Genetics · doi:10.1038/s41588-021-00904-0 · Cited by 69
Hsp90 chaperones hemoglobin maturation in erythroid and nonerythroid cells
Ghosh, A., Garee, G., Sweeny, E. A., Nakamura, Y., & Stuehr, D. J. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1717993115 · Cited by 62
“We then performed experiments with the human erythroid progenitor cells HiDEP-1 and HUDEP-2, which can be induced by culturing in differentiation media with erythropoietin (EPO) and growth factors to undergo full differentiation to erythroid cells that produce fetal (Hb-α/γ) or adult (Hb-α/β) hemoglobins, respectively…”
MethodSelf-citationTransferrin Receptors in Erythropoiesis
Richard, C., & Verdier, F. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249713 · Cited by 69
“Considering the higher expression of TFR2 in human erythroblasts compared with murine erythroblasts [4,65], further studies in human models such as the human erythroid cell lines BelA [66] or Hudep2 [67] would help to better understand the role of TFR2 in erythropoiesis.”
BackgroundTopfer, S. K., Feng, R., Huang, P., Ly, L. C., Martyn, G. E., Blobel, G. A., Weiss, M. J., Quinlan, K. G. R., & Crossley, M. (2022) · Blood · doi:10.1182/blood.2021014205 · Cited by 63
Yu, X., Azzo, A., Bilinovich, S. M., Li, X., Dozmorov, M. G., Kurita, R., Nakamura, Y., Williams, D. C., & Ginder, G. D. (2019) · Haematologica · doi:10.3324/haematol.2018.210963 · Cited by 66
“The zinc finger transcription factors BCL11A and LRF have been shown to independently exert especially strong silencing of the g-globin gene in an immortalized Human Umbilical cord Derived Erythroid Progenitor-2 (HUDEP-2) cell line that displays an adult erythroid phenotype.(13,17) In addition to transcription factors…”
BackgroundResultSelf-citationSivalingam, J., SuE, Y., Lim, Z. R., Lam, A. T., Lee, A., Lim, H. L., Chen, H. Y., Tan, H. K., Warrier, T., Hang, J. W., et al. (2020) · Stem Cell Reports · doi:10.1016/j.stemcr.2020.11.008 · Cited by 61
“Other groups have also immortalized adult erythroblasts to produce RBCs (Trakarnsanga et al., 2017; Kurita et al., 2013; Hirose et al., 2013).”
BackgroundSingle-nucleotide-level mapping of DNA regulatory elements that control fetal hemoglobin expression
Cheng, L., Li, Y., Qi, Q., Xu, P., Feng, R., Palmer, L. E., Chen, J., Wu, R., Yee, T., Zhang, J., et al. (2021) · Nature Genetics · doi:10.1038/s41588-021-00861-8 · Cited by 60
Ma, Y., Liu, S., Gao, J., Chen, C., Zhang, X., Yuan, H., Chen, Z., Yin, X., Sun, C., Mao, Y., et al. (2021) · Developmental Cell · doi:10.1016/j.devcel.2020.12.019 · Cited by 66
Self-citationHIC2 controls developmental hemoglobin switching by repressing BCL11A transcription
Huang, P., Peslak, S. A., Ren, R., Khandros, E., Qin, K., Keller, C. A., Giardine, B. M., Bell, H. W., Lan, X., Sharma, M., et al. (2022) · Nature Genetics · doi:10.1038/s41588-022-01152-6 · Cited by 63
Cas9 protein delivery non-integrating lentiviral vectors for gene correction in sickle cell disease
Uchida, N., Drysdale, C. M., Nassehi, T., Gamer, J., Yapundich, M., DiNicola, J., Shibata, Y., Hinds, M., Gudmundsdottir, B., Haro-Mora, J. J., et al. (2021) · Molecular Therapy - Methods & Clinical Development · doi:10.1016/j.omtm.2021.02.022 · Cited by 55
“Yukio Nakamura and Ryo Kurita, RIKEN Tsukuba Branch, Ibaraki, Japan) including the SCD mutation was edited with the bs-globin-targeting guide RNA (SG11: 50-GTA ACG GCA GAC TTC TCCAC-30), cultured in proliferation media based on StemSpan Serum-Free ExpansionMedium (STEMCELL Technologies, Vancouver, BC, Canada) containi…”
MethodGeneration of transgene-free hematopoietic stem cells from human induced pluripotent stem cells
Piau, O., Brunet-Manquat, M., L’Homme, B., Petit, L., Birebent, B., Linard, C., Moeckes, L., Zuliani, T., Lapillonne, H., Benderitter, M., et al. (2023) · Cell stem cell · doi:10.1016/j.stem.2023.11.002 · Cited by 69
Mao, B., Huang, S.-K., Lu, X., Sun, W., Zhou, Y., Pan, X., Yu, J., Lai, M., Chen, B., Zhou, Q., et al. (2016) · Stem Cell Reports · doi:10.1016/j.stemcr.2016.09.002 · Cited by 60
“Many efforts have also been made for the efficient large-scale manufacture of hPSCderived erythrocytes (Slukvin, 2010; Olivier et al., 2012; Perugini et al., 2009; Smith et al., 2013; Kurita et al., 2013).”
BackgroundZhou, Z., Giles, K. E., & Felsenfeld, G. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1900107116 · Cited by 56
“To address this question, we used HUDEP-2 cells, an immortalized human umbilical cord blood-derived erythroid progenitor cell line that expresses β-globin predominately over γ-globin (42, 43).”
MethodReactivation of a developmentally silenced embryonic globin gene
King, A. J., Songdej, D., Downes, D. J., Beagrie, R. A., Liu, S., Buckley, M., Peng, H., Suciu, M., Oudelaar, A. M., Hanssen, L. L. P., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-24402-3 · Cited by 62
Concise Review: Stem Cell-Based Approaches to Red Blood Cell Production for Transfusion
Shah, S., Huang, X., & Cheng, L. (2013) · Stem Cells Translational Medicine · doi:10.5966/sctm.2013-0054 · Cited by 56
Ito, N., Kii, I., Shimizu, N., Tanaka, H., & Takeda, S. (2017) · Scientific Reports · doi:10.1038/s41598-017-08232-2 · Cited by 60
Human‐induced pluripotent stem cell‐derived blood products: state of the art and future directions
Hansen, M., Lindern, M. V., van den Akker, E., & Varga, E. (2019) · FEBS Letters · doi:10.1002/1873-3468.13599 · Cited by 57
Han, W., Qiu, H.-Y., Sun, S., Fu, Z.-C., Wang, G., Qian, X., Wang, L., Zhai, X., Jia, W. P., Wang, Y., et al. (2023) · Cell stem cell · doi:10.1016/j.stem.2023.10.007 · Cited by 55
McQuaid, F., & Rowe, J. A. (2019) · Parasitology · doi:10.1017/s0031182019001288 · Cited by 51
“The development of immortalized erythroid lines (Kurita et al., 2013; Kanjee et al., 2017; Trakarnsanga et al., 2017; Scully et al., 2019) may overcome this limitation.”
BackgroundTakase, S., Hiroyama, T., Shirai, F., Maemoto, Y., Nakata, A., Arata, M., Matsuoka, S., Sonoda, T., Niwa, H., Sato, S., et al. (2023) · Nature Communications · doi:10.1038/s41467-022-35404-0 · Cited by 56
Self-citationFujita, A., Uchida, N., Haro‐Mora, J. J., Winkler, T., & Tisdale, J. F. (2016) · Stem Cells · doi:10.1002/stem.2335 · Cited by 57
Cruz, L. J., van Dijk, T., Vepris, O., Li, T. M. W. Y., Schomann, T., Baldazzi, F., Kurita, R., Nakamura, Y., Grosveld, F. G., Philipsen, S., et al. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.120580 · Cited by 53
“Human umbilical cord blood-derived erythroid progenitor-2 (HUDEP-2) were cultured as described previously [38].”
MethodSelf-citationHuang, X., Shah, S., Wang, J., Ye, Z., Dowey, S. N., Tsang, K. M., Mendelsohn, L. G., Kato, G. J., Kickler, T. S., & Cheng, L. (2013) · Molecular Therapy · doi:10.1038/mt.2013.201 · Cited by 51
Ex vivo editing of human hematopoietic stem cells for erythroid expression of therapeutic proteins
Pavani, G., Laurent, M., Fabiano, A., Cantelli, E., Sakkal, A., Corre, G., Lenting, P. J., Concordet, J.-P., Toueille, M., Miccio, A., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17552-3 · Cited by 49
Alteration of genome folding via contact domain boundary insertion
Zhang, D., Huang, P., Sharma, M., Keller, C. A., Giardine, B., Zhang, H., Gilgenast, T. G., Phillips-Cremins, J. E., Hardison, R. C., & Blobel, G. A. (2020) · Nature Genetics · doi:10.1038/s41588-020-0680-8 · Cited by 49
HMGB1-mediated restriction of EPO signaling contributes to anemia of inflammation
Dulmovits, B. M., Tang, Y., Papoin, J., He, M., Li, J., Yang, H., Addorisio, M. E., Kennedy, L. P., Khan, M., Brindley, E. C., et al. (2022) · Blood · doi:10.1182/blood.2021012048 · Cited by 53
Self-citationVinjamur, D. S., & Bauer, D. E. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-7428-3_17 · Cited by 48
A Cell-Permeant Nanobody-Based Degrader That Induces Fetal Hemoglobin
Shen, F., Zheng, G., Setegne, M. T., Tenglin, K., Izadi, M., Xie, H. T. H., Zhai, L., Orkin, S. H., & Dassama, L. M. K. (2022) · ACS Central Science · doi:10.1021/acscentsci.2c00998 · Cited by 55
“3-2D9 to the lysate of human umbilical cord blood-derived erythroid progenitor (HUDEP-2) cells (33) confirmed their association with endogenous, fulllength BCL11A (Fig.”
Hu, Y., Stilp, A. M., McHugh, C., Rao, S., Jain, D., Zheng, X., Lane, J., de Bellefon, S. M., Raffield, L. M., Chen, M., et al. (2021) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2021.04.003 · Cited by 51
GAPDH is involved in the heme‐maturation of myoglobin and hemoglobin
Tupta, B., Stuehr, E., Sumi, M. P., Sweeny, E. A., Smith, B., Stuehr, D. J., & Ghosh, A. (2021) · The FASEB Journal · doi:10.1096/fj.202101237rr · Cited by 46
Lee, J., Park, J., Kwon, O., Lee, T.-H., Nakano, I., Miyoshi, H., Chun, K., Park, M., Lee, H. J., Kim, S. U., et al. (2014) · Neuro-Oncology · doi:10.1093/neuonc/nou145 · Cited by 48
“This plasmid was constructed in the CSIV-TRE-RfA-UbC-KT vector using Gateway Technology with clonase II (Invitrogen) as described previously.(20)”
MethodSelf-citationFANCI-FANCD2 stabilizes the RAD51-DNA complex by binding RAD51 and protects the 5′-DNA end
Sato, K., Shimomuki, M., Katsuki, Y., Takahashi, D., Kobayashi, W., Ishiai, M., Miyoshi, H., Takata, M., & Kurumizaka, H. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw876 · Cited by 50
“The resulting vector was transferred into a puromycin-resistant derivative of CSIV-TRE-RfA-UbC-KT (46), using LR Clonase (Invitrogen).”
Self-citationQi, Q., Li, C., Tang, X., He, Y., Li, Y., Yee, T., Shrestha, D., Feng, R., Xu, P., Zhou, X., et al. (2020) · Blood · doi:10.1182/blood.2020005780 · Cited by 46
Comparing the two leading erythroid lines BEL-A and HUDEP-2
Daniels, D. E., Downes, D. J., Vicens, I. F., Ferguson, D. C. J., Singleton, B. K., Wilson, M. C., Trakarnsanga, K., Kurita, R., Nakamura, Y., Anstee, D. J., et al. (2019) · Haematologica · doi:10.3324/haematol.2019.229211 · Cited by 46
“Following induction of E6/E7 expression in early erythroblasts, both lines were transferred to the same expansion medium.(4,5) A schematic of the protocols is shown in Figure 1A.”
MethodSelf-citationChoudhuri, A., Trompouki, E., Abraham, B. J., Colli, L. M., Kock, K. H., Mallard, W., Yang, M.-L., Vinjamur, D. S., Ghamari, A., Sporrij, A., et al. (2020) · Nature Genetics · doi:10.1038/s41588-020-00738-2 · Cited by 46
Hemoglobin genetics: recent contributions of GWAS and gene editing
Smith, E. C., & Orkin, S. H. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw170 · Cited by 45
“In the normal adult, adult hemoglobin (HbA, a2b2) comprises>95% of total hemoglobin and fetal hemoglobin (HbF, a2b2) 1–2%.”
BackgroundInfluentialUchida, N., Haro‐Mora, J. J., Fujita, A., Lee, D., Winkler, T., Hsieh, M. M., & Tisdale, J. F. (2016) · Stem Cells · doi:10.1002/stem.2517 · Cited by 47
Morrison, T. A., Wilcox, I., Luo, H., Farrell, J. J., Kurita, R., Nakamura, Y., Murphy, G. J., Cui, S., Steinberg, M. H., & Chui, D. H. K. (2017) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2017.11.003 · Cited by 51
“HUDEP cells are immortalized erythroid cell lines derived from cord blood CD34 mononuclear cells [14].”
BackgroundMethodSelf-citationLeung, A., Zulick, E., Skvir, N. J., Vanuytsel, K., Morrison, T. A., Naing, Z. H., Wang, Z., Dai, Y., Chui, D. H. K., Steinberg, M. H., et al. (2018) · Stem Cells · doi:10.1002/stem.2822 · Cited by 49
Li, C., Mishra, A., Gil, S., Wang, M., Georgakopoulou, A., Papayannopoulou, T., Hawkins, R. D., & Lieber, A. (2019) · Molecular Therapy · doi:10.1016/j.ymthe.2019.08.006 · Cited by 47
“We used HUDEP-2 cells, an immortalized human erythroid precursor cell line.(36) This cell line allows the expansion of single colonies, features that facilitate integration site analysis.”
MethodKarayel, Ö., Xu, P., Bludau, I., Bhoopalan, S. V., Yao, Y., Rita, F. C. A., Santos, A., Schulman, B. A., Alpi, A. F., Weiss, M. J., et al. (2020) · Molecular Systems Biology · doi:10.15252/msb.20209813 · Cited by 50
“Tyrosine phosphorylation in the c-Kit cytoplasmic domain, which reflects receptor activity (Lennartsson & Ronnstrand, 2012), was maximal in erythroid progenitors and ProE/EBaso and decreased by the LBaso stage, even with SCF present in the culture media (Fig 6E and F).”
Xu, P., Scott, D. C., Xu, B., Yao, Y., Feng, R., Cheng, L., Mayberry, K. D., Wang, Y., Bi, W., Palmer, L. E., et al. (2020) · Blood · doi:10.1182/blood.2020007809 · Cited by 45
Scully, E. J., Shabani, E., Rangel, G. W., Grüring, C., Kanjee, U., Clark, M. A., Chaand, M., Kurita, R., Nakamura, Y., Ferreira, M. U., et al. (2019) · American Journal of Hematology · doi:10.1002/ajh.25543 · Cited by 47
Self-citationDual function NFI factors control fetal hemoglobin silencing in adult erythroid cells
Qin, K., Huang, P., Feng, R., Keller, C. A., Peslak, S. A., Khandros, E., Saari, M. S., Lan, X., Mayuranathan, T., Doerfler, P. A., et al. (2022) · Nature Genetics · doi:10.1038/s41588-022-01076-1 · Cited by 46
GATA Factor-Mediated Gene Regulation in Human Erythropoiesis
Romano, O., Petiti, L., Félix, T., Meneghini, V., Portafax, M., Antoniani, C., Amendola, M., Bicciato, S., Peano, C., & Miccio, A. (2020) · iScience · doi:10.1016/j.isci.2020.101018 · Cited by 44
Shang, S., Li, X., Azzo, A., Truong, T., Dozmorov, M. G., Lyons, C. E., Manna, A. K., Williams, D. C., & Ginder, G. D. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2302254120 · Cited by 47
“HUDEP2 cells were maintained and expanded by the method described previously (10, 16) and were kindly provided by Yukio Nakamura.”
Lee, E., Sivalingam, J., Lim, Z., Chia, G., Shi, L. G., Roberts, M., Loh, Y., Reuveny, S., & Oh, S. (2018) · Biotechnology Advances · doi:10.1016/j.biotechadv.2018.09.006 · Cited by 37
Khandros, E., Huang, P., Peslak, S. A., Sharma, M., Abdulmalik, O., Giardine, B. M., Zhang, Z., Keller, C. A., Hardison, R. C., & Blobel, G. A. (2020) · Blood · doi:10.1182/blood.2020005058 · Cited by 40
Mehta, S., Buyanbat, A., Yan, K., Karayel, Ö., Goldman, S. R., Seruggia, D., Zhang, K., Fujiwara, Y., Donovan, K. A., Zhu, Q., et al. (2022) · Cell chemical biology · doi:10.1016/j.chembiol.2022.06.007 · Cited by 45
BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression
Yu, L., Jearawiriyapaisarn, N., Lee, M. P., Hosoya, T., Wu, Q., Myers, G., Lim, K.-C., Kurita, R., Nakamura, Y., Vojtek, A. B., et al. (2018) · Genes & Development · doi:10.1101/gad.318436.118 · Cited by 39
“Materials and methods HUDEP-2 cell culture HUDEP-2 cells were the kind gift of Dr. Yukio Nakamura (Kurita et al. 2013).”
MethodSelf-citationATF4 Regulates MYB to Increase γ-Globin in Response to Loss of β-Globin
Boontanrart, M. Y., Schröder, M., Stehli, G., Banović, M., Wyman, S. K., Lew, R. J., Bordi, M., Gowen, B. G., DeWitt, M. A., & Corn, J. E. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107993 · Cited by 41
Metadata
- Authors
- Kurita, R., Suda, N., Sudo, K., Miharada, K., Hiroyama, T., Miyoshi, H., Tani, K., & Nakamura, Y.
- Affiliations
- RIKEN BioResource Research Center (JP)
- Kyushu University (JP)
- Corresponding author
- Nakamura, Yukio
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2013-03-22
- Volume
- 8
- Issue
- 3
- Pages
- e59890
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3606290
- OpenAlex
- W1974742081
- Cited by
- 418
- References
- 28
- Citations by year
- 2026: 38 · 2025: 43 · 2024: 34 · 2023: 36 · 2022: 35 · 2021: 48 · 2020: 45 · 2019: 31 · 2018: 32 · 2017: 24 · 2016: 25 · 2015: 10 · 2014: 8 · 2013: 8
- FWCI
- 12.19
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- Ministry of Education, Culture, Sports, Science and Technology
- RIKEN
- RIKEN Brain Science Institute
- Topics
- Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
- Health Sciences › Medicine › Hematology › Blood transfusion and management
- Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
- Keywords
- erythroid progenitor cells, immortalized cell lines, in vitro erythropoiesis, blood transfusion, erythroid differentiation
- MeSH terms
- Cell Nucleus, Erythrocytes, Erythropoiesis, Humans, Erythroid Precursor Cells, Erythrocyte Transfusion
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.